about
Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactionsPhase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapyManagement of thrombocytopenia due to liver cirrhosis: a reviewThe role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Romiplostim treatment allows for platelet transfusion-free liver transplantation in pediatric thrombocytopenic patient with primary sclerosing cholangitis.Posttransfusion purpura occurrence and potential risk factors among the inpatient US elderly, as recorded in large Medicare databases during 2011 through 2012.Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.Hospital-acquired thrombocytopenia.Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.Anemia status, hemoglobin concentration and outcome after acute stroke: a cohort study.Suspected Transfusion Related Acute Lung Injury Improving following Administration of Tranexamic Acid: A Case Report.Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: a retrospective analysis.Synthetic polymers enable non-vitreous cellular cryopreservation by reducing ice crystal growth during thawing.Pseudomonas fluorescens contamination of a feline packed red blood cell unit and studies of canine units.Intraoperative blood transfusion of one or two units of packed red blood cells is associated with a fivefold risk of stroke in patients undergoing elective carotid endarterectomy.Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?What every physician should know about transfusion reactions.In vitro lysis and acute transfusion reactions with hemolysis caused by inappropriate storage of canine red blood cell products.Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children.Preparation of ultrapure bovine and human hemoglobin by anion exchange chromatography.Transfusion premedications: a growing practice not based on evidence.Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.Descriptions of acute transfusion reactions in the teaching hospitals of kermanshah university of medical sciences, iranChanges in band 3 structure as determinants of erythrocyte integrity during storage and survival after transfusion.Bleeding complications of unfractionated heparin.Changes in cerebral blood flow in children with sickle cell disease after splenectomy.Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.Effect of premedication and other factors on the occurrence of acute transfusion reactions in dogs.Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012.A revised classification scheme for acute transfusion reactions.Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.Evaluation of Four Bedside Test Systems for Card Performance, Handling and Safety.A detection of unexpected blood antibody at the time of transfusion was needed, during the operation -A case report-.Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention.Comparison of RBCs and FFP with whole blood during liver transplant surgery.Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database.The effect of patient-controlled analgesia on coadministered red blood cells.Blood transfusion practice in critically ill patients: a single institutional experience.Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction.Hemochromatosis secondary to repeated blood transfusions in a dog.
P2860
Q24234953-C8B53683-FC69-4EE5-AC59-D41335632ED8Q33390778-AD135AE7-B9C7-44C2-91EE-4AB8E9391155Q33413924-3D48E279-5077-49B9-8314-FE655EC575DFQ33414386-D12ECE44-447E-4007-901E-4F415FE51799Q33416575-EB074A5F-3FC0-4850-A8CF-19FB59983942Q33416749-4CB4070B-A1D5-40BF-A4F7-866B20FC3BE2Q33418708-C8C3D144-73C2-4DA9-A71A-2084EAA722DBQ33419312-6FB1B64F-8FE2-4058-B9E7-0D43E65D061FQ33427048-C32F9B14-10C3-4B4B-978A-7331658601A5Q33551473-FFEE3C96-7095-43E5-AE62-D7A612ACA4C2Q33786973-DEA7719E-FEE0-47DD-AA49-191251654830Q33953454-72C6E3DE-17D8-411D-A1FC-45A7AE36CB50Q34401621-1B935875-0E11-4134-BCDC-0F2A78389E8AQ35037164-29E27F72-6B83-4D48-B27E-E8EE317D426EQ35346336-CD46ABC0-8154-4BE7-8884-F5B1C34B00C8Q35792449-C3CCCA18-C2E7-403F-9AB1-CCD41A1BD541Q35878583-61D9ED6F-6BB2-4612-B118-1C644797C524Q36099493-C0D0F83F-1921-478A-B7BD-363926A5074EQ36237664-33B6AAD4-9361-4F83-9F7E-394B616D15EFQ36724726-03BC5A44-7C07-4394-BDF8-E4026C4300F2Q36831189-0252F946-587F-4291-9C2B-C4B7DA36267CQ36892870-C5FA6079-496A-460A-BC14-FD295740E49AQ37552707-A1154D72-4AE8-4BDC-B6C6-3E0A59688E7FQ37770411-128C1A1C-CC61-4907-99BA-5FB61A64B8ECQ37792099-4C843F1D-7757-473D-A1B7-ACE433F6BBF2Q38420178-CC814CFD-906A-4964-BE1E-98250E87EECBQ38534070-100AE632-DAD0-47F8-960F-D768A0035B24Q40150149-A3A99461-A541-4D4C-9505-B5299238A919Q40179540-92E35885-EA72-4D3F-BA83-443AA1774C60Q40454545-931D4716-0F2F-4D67-A5FA-2D1BE5413332Q40543301-19A848B6-1001-452F-BF59-F8C0E85AFC44Q42722766-99EFB12D-08DC-494A-B087-E7743AE941BBQ43068150-0E89590F-E802-40B2-91CF-6D9D37A69368Q44068850-CF876EB3-47F7-417B-A406-02D16603D38CQ46301567-A5170692-33B1-4318-8399-5818070B1458Q46702363-D8191E89-978D-4F2C-B580-C72BB63CB056Q46988004-DAC79883-CEAD-4A77-B493-82B3CA6846FAQ47677658-E1A6389D-79E7-4AB6-B57B-AF8CEFDB3C6CQ50053079-DC232690-3277-466E-9DC8-61619B968609Q50494693-BE9F8231-698D-492B-BCC2-216202EEAEBA
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Non-infectious complications of transfusion therapy.
@ast
Non-infectious complications of transfusion therapy.
@en
Non-infectious complications of transfusion therapy.
@nl
type
label
Non-infectious complications of transfusion therapy.
@ast
Non-infectious complications of transfusion therapy.
@en
Non-infectious complications of transfusion therapy.
@nl
prefLabel
Non-infectious complications of transfusion therapy.
@ast
Non-infectious complications of transfusion therapy.
@en
Non-infectious complications of transfusion therapy.
@nl
P356
P1433
P1476
Non-infectious complications of transfusion therapy.
@en
P2093
Perrotta PL
P356
10.1054/BLRE.2001.0151
P577
2001-06-01T00:00:00Z